FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2051056852> ?p ?o ?g. }

• W2051056852 endingPage "336" @default.
• W2051056852 startingPage "328" @default.
• W2051056852 abstract "Summary: Purpose: Perimenstrual catamenial epilepsy, the increase in seizure frequency that some women with epilepsy experience near the time of menstruation, may in part be related to withdrawal of the progesterone metabolite allopregnanolone, an endogenous anticonvulsant neurosteroid that is a potent positive allosteric γ‐aminobutyric acid A (GABA A ) receptor modulator. The objective of this study was to develop an animal model of perimenstrual catamenial epilepsy for use in evaluating drug‐treatment strategies. Methods: A state of prolonged high serum progesterone (pseudopregnancy) was induced in 26‐day‐old female rats by sequential injection of pregnant mares' serum gonadotropin and human chorionic gonadotropin. Neurosteroid withdrawal was induced by treatment with finasteride (100 mg/kg, i.p.), a 5α‐reductase inhibitor that blocks the conversion of progesterone to allopregnanolone. Plasma progesterone and allopregnanolone levels were measured by gas chromatography/electron capture negative chemical ionization mass spectrometry. Seizure susceptibility was evaluated with the convulsant pentylenetetrazol (PTZ). Results: Plasma allopregnanolone levels were markedly increased during pseudopregnancy (peak level, 55.1 vs. control diestrous level, 9.3 ng/mL) and were reduced by 86% 24 h after finasteride treatment (6.4 ng/mL). Progesterone levels were unaffected by finasteride. After finasteride‐induced withdrawal, rats showed increased susceptibility to PTZ seizures. There was a significant increase in the number of animals exhibiting clonic seizures when challenged with subcutaneous PTZ (60 mg/kg) compared with control pseudopregnant animals not undergoing withdrawal and nonpseudopregnant diestrous females. The CD 50 (50% convulsant dose) was 46 mg/kg, compared with 73 mg/kg in nonwithdrawn pseudopregnant animals and 60 mg/kg in diestrous controls. The threshold doses for induction of various seizure signs, measured by constant intravenous infusion of PTZ, were reduced by 30–35% in neurosteroid‐withdrawing animals compared with control diestrous females. No change in threshold was observed in pseudopregnant rats treated from days 7 to 11 with finasteride, demonstrating that high levels of progesterone alone do not alter seizure reactivity. Conclusions: Neurosteroid withdrawal in pseudopregnant rats results in enhanced seizure susceptibility, providing an animal model of perimenstrual catamenial epilepsy that can be used for the evaluation of new therapeutic approaches." @default.
• W2051056852 created "2016-06-24" @default.
• W2051056852 creator A5002821906 @default.
• W2051056852 creator A5004551722 @default.
• W2051056852 creator A5034295757 @default.
• W2051056852 date "2001-03-09" @default.
• W2051056852 modified "2023-10-16" @default.
• W2051056852 title "Neurosteroid Withdrawal Model of Perimenstrual Catamenial Epilepsy" @default.
• W2051056852 cites W1647312149 @default.
• W2051056852 cites W1771372085 @default.
• W2051056852 cites W1972888313 @default.
• W2051056852 cites W1986161509 @default.
• W2051056852 cites W1989377572 @default.
• W2051056852 cites W1995644293 @default.
• W2051056852 cites W2006646026 @default.
• W2051056852 cites W2008392190 @default.
• W2051056852 cites W2011191676 @default.
• W2051056852 cites W2013860530 @default.
• W2051056852 cites W2024258285 @default.
• W2051056852 cites W2024344189 @default.
• W2051056852 cites W2034812041 @default.
• W2051056852 cites W2038415949 @default.
• W2051056852 cites W2040726282 @default.
• W2051056852 cites W2042563099 @default.
• W2051056852 cites W2043414873 @default.
• W2051056852 cites W2044866059 @default.
• W2051056852 cites W2049710739 @default.
• W2051056852 cites W2054060583 @default.
• W2051056852 cites W2057911940 @default.
• W2051056852 cites W2059006254 @default.
• W2051056852 cites W2059327991 @default.
• W2051056852 cites W2061549777 @default.
• W2051056852 cites W2065556700 @default.
• W2051056852 cites W2068359965 @default.
• W2051056852 cites W2068566957 @default.
• W2051056852 cites W2068781003 @default.
• W2051056852 cites W2069777998 @default.
• W2051056852 cites W2071924525 @default.
• W2051056852 cites W2073081959 @default.
• W2051056852 cites W2074113629 @default.
• W2051056852 cites W2081985979 @default.
• W2051056852 cites W2081999375 @default.
• W2051056852 cites W2084209480 @default.
• W2051056852 cites W2089056970 @default.
• W2051056852 cites W2104685361 @default.
• W2051056852 cites W2118790060 @default.
• W2051056852 cites W2121587872 @default.
• W2051056852 cites W2124151108 @default.
• W2051056852 cites W2130793280 @default.
• W2051056852 cites W2136044742 @default.
• W2051056852 cites W2228758490 @default.
• W2051056852 cites W2314635005 @default.
• W2051056852 cites W4233635697 @default.
• W2051056852 cites W4243782770 @default.
• W2051056852 doi "https://doi.org/10.1046/j.1528-1157.2001.10100.x" @default.
• W2051056852 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11442149" @default.
• W2051056852 hasPublicationYear "2001" @default.
• W2051056852 type Work @default.
• W2051056852 sameAs 2051056852 @default.
• W2051056852 citedByCount "137" @default.
• W2051056852 countsByYear W20510568522012 @default.
• W2051056852 countsByYear W20510568522013 @default.
• W2051056852 countsByYear W20510568522014 @default.
• W2051056852 countsByYear W20510568522015 @default.
• W2051056852 countsByYear W20510568522016 @default.
• W2051056852 countsByYear W20510568522017 @default.
• W2051056852 countsByYear W20510568522018 @default.
• W2051056852 countsByYear W20510568522019 @default.
• W2051056852 countsByYear W20510568522020 @default.
• W2051056852 countsByYear W20510568522021 @default.
• W2051056852 countsByYear W20510568522022 @default.
• W2051056852 countsByYear W20510568522023 @default.
• W2051056852 crossrefType "journal-article" @default.
• W2051056852 hasAuthorship W2051056852A5002821906 @default.
• W2051056852 hasAuthorship W2051056852A5004551722 @default.
• W2051056852 hasAuthorship W2051056852A5034295757 @default.
• W2051056852 hasBestOaLocation W20510568521 @default.
• W2051056852 hasConcept C118552586 @default.
• W2051056852 hasConcept C121608353 @default.
• W2051056852 hasConcept C126322002 @default.
• W2051056852 hasConcept C134018914 @default.
• W2051056852 hasConcept C168258287 @default.
• W2051056852 hasConcept C170493617 @default.
• W2051056852 hasConcept C185592680 @default.
• W2051056852 hasConcept C2775858608 @default.
• W2051056852 hasConcept C2775874879 @default.
• W2051056852 hasConcept C2776235491 @default.
• W2051056852 hasConcept C2776819090 @default.
• W2051056852 hasConcept C2777477808 @default.
• W2051056852 hasConcept C2778186239 @default.
• W2051056852 hasConcept C2778338918 @default.
• W2051056852 hasConcept C2778460930 @default.
• W2051056852 hasConcept C2778900099 @default.
• W2051056852 hasConcept C44796713 @default.
• W2051056852 hasConcept C71924100 @default.
• W2051056852 hasConcept C98274493 @default.
• W2051056852 hasConceptScore W2051056852C118552586 @default.
• W2051056852 hasConceptScore W2051056852C121608353 @default.

• next